Network origin in Martyn D. Williams first degree
Entity | Entity type | Industry | |
---|---|---|---|
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom.
20
| Extinct | Miscellaneous Commercial Services | 20 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Martyn D. Williams via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Cable & Wireless Ltd.
Cable & Wireless Ltd. Major TelecommunicationsCommunications Cable & Wireless Ltd. operates as a telecommunications company. The company was founded in 1929 and is headquartered in London, the United Kingdom. | Major Telecommunications | Director of Finance/CFO | |
BAYER AG | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
ADECCO GROUP AG | Personnel Services | Director/Board Member | |
VECTURA GROUP | Pharmaceuticals: Major | Director/Board Member | |
RENEURON GROUP PLC | Pharmaceuticals: Major | Chairman Director/Board Member | |
The Chartered Institute of Management Accountants
The Chartered Institute of Management Accountants Other Consumer ServicesConsumer Services The Chartered Institute of Management Accountants, also known as aicpa® & cima®, is a global organization with 689,000 members, students, and professionals. The non-profit company is based in London, UK, and has a global presence of subsidiaries in several regions. The British company advocates for the accounting and finance profession, as well as the public interest and business sustainability. Andrew Harding has been the CEO of the company since 2009. | Other Consumer Services | Corporate Officer/Principal | |
PCCW LIMITED | Major Telecommunications | Director of Finance/CFO | |
SMARTONE TELECOMMUNICATIONS HOLDINGS LIMITED | Wireless Telecommunications | Director/Board Member | |
SUNEVISION HOLDINGS LTD. | Data Processing Services | Director/Board Member | |
Cobra Biologics Holdings Ltd.
Cobra Biologics Holdings Ltd. BiotechnologyHealth Technology Cobra Biomanufacturing Plc manufactures biological products for clinical studies and clients in the pharmaceutical and biotech industries. It designs and manufactures novel proteins, viruses and additional cell products. It provides DNA-based technologies, services and products. Its services include: DNA, virus and protein manufacturing, cell banking, process development, analytical services and quality assurance and regulatory support. It uses mammalian and microbial host cells for numerous therapeutic protein developments. It also provides a range of DNA maintenance technology, such as its ORT, ORT-VAC and RiboCLEAR programs. The company is headquartered in Newcastle, the United Kingdom. | Biotechnology | Director/Board Member | |
Imperial College London | College/University | Doctorate Degree | |
The University of Southampton | College/University | Doctorate Degree | |
University of London | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
University of Birmingham | College/University | Undergraduate Degree | |
The University of Hull | College/University | Undergraduate Degree | |
Lifearc
Lifearc Miscellaneous Commercial ServicesCommercial Services Lifearc provides research services. It specializes in intellectual property management, drug discovery, medical diagnostics and antibody engineering. The firm services include complete technology transfer service for scientists in MRC units and institutes, Awards to Inventors, Collaborative drug discovery and antibody engineering, Funding early stage research with commercial/translational potential and protecting new ideas. The company is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Bayer Pharma AG
Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Sales & Marketing | |
The Royal College of Physicians | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
PINNACLE INVESTMENT MANAGEMENT GROUP LIMITED | Investment Managers | Director/Board Member | |
Glaxo Group Research Ltd. | Corporate Officer/Principal Corporate Officer/Principal | ||
Celentyx Ltd.
Celentyx Ltd. BiotechnologyHealth Technology Celentyx Ltd. provides research and development on human immune disease. The firm's services include rapid analysis screening of drug action on physiological and pathological human immune tissues and cells. It provides services by disease, cell type, assay through its ImmuKnowlogy platform technology. The company was founded by Nicholas Mark Barnes and John Gordon in 2004 and is headquartered in Birmingham, the United Kingdom. | Biotechnology | Director/Board Member | |
Takeda Europe Research & Development Centre
Takeda Europe Research & Development Centre Miscellaneous Commercial ServicesCommercial Services Takeda Europe Research & Development Centre is a British company that specializes in Biological Research. The private company is based in London, UK. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Spark Therapeutics Ireland Ltd.
Spark Therapeutics Ireland Ltd. Pharmaceuticals: MajorHealth Technology Spark Therapeutics Ireland Ltd. develops new gene medicines to treat autosomal dominant genetic diseases. Its product RhoNova, is designed for the treatment of patients with rhodopsin linked autosomal dominant retinitis pigmentosa, a debilitating, progressive form of inherited blindness resulting from a diverse array of mutations in the RHO gene. The company was founded by Jane G. Farrar, Paul Kenna, and Gearóid Tuohy and is headquartered in Dublin, Ireland. | Pharmaceuticals: Major | Director/Board Member | |
The Engineering & Physical Sciences Research Council
The Engineering & Physical Sciences Research Council Miscellaneous Commercial ServicesCommercial Services The Engineering & Physical Sciences Research Council provides funds for research and training in engineering and the physical sciences. It covers range of subjects from mathematics to material science and from information technology to structural engineering. The firm offers services to the users and beneficiaries of chemical, communications, construction, electrical, electronic, energy, engineering, information technology, pharmaceutical, process and other industries. The company was founded in 1994 and is headquartered in Swindon, the United Kingdom. | Miscellaneous Commercial Services | Chairman | |
The Babraham Institute
The Babraham Institute Miscellaneous Commercial ServicesCommercial Services Babraham Institute operates as charitable life sciences organization. It is a registered charity, sponsored by the Biotechnology and Biological Sciences Research Council. Babraham Institute is headquartered in Cambridge, GB. | Miscellaneous Commercial Services | Chairman | |
Chartered Institute of Purchasing & Supply | Corporate Officer/Principal | ||
Celltech Group Ltd.
Celltech Group Ltd. Financial ConglomeratesFinance Part of UCB SA, Celltech Group Ltd. is an investment holding British company. The company is based in Slough, UK. Celltech Group was founded in 1987. | Financial Conglomerates | Chief Tech/Sci/R&D Officer | |
Cyclacel Ltd. | Director/Board Member | ||
Zeneca Pharmaceuticals
Zeneca Pharmaceuticals Pharmaceuticals: MajorHealth Technology Zeneca Pharmaceuticals manufactures medicines. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Endomagnetics Ltd.
Endomagnetics Ltd. Packaged SoftwareTechnology Services Endomagnetics Ltd. develops surgical instruments used in the treatment of cancer. It offers SentiMag, a surgical instrument for use in the treatment of breast cancer and melanoma by helping surgeons to identify the sentinel lymph node for excision and subsequent histology to determine whether cancer has spread from a nearby tumor site. The company was founded by Quentin Pankhurst, Simon Hattersley, and Audrius Brazdeikis in April 2007 and is headquartered in Cambridge, the United Kingdom. | Packaged Software | Director/Board Member | |
Alan Boyd Consultants Ltd. | Chief Executive Officer | ||
CLINIGEN GROUP PLC | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Bioscience Managers Pty Ltd.
Bioscience Managers Pty Ltd. Investment ManagersFinance BioScience Managers Pty Ltd (Bioscience Managers) is a private equity & venture capital firm founded in 2003 by Jeremy Curnock Cook. The firm is headquartered in Melbourne, Australia. | Investment Managers | Consultant / Advisor | |
Congenica Ltd.
Congenica Ltd. BiotechnologyHealth Technology Congenica Ltd. develops genome-based discovery and diagnostic technologies. It uses Sapientia technology platform, which allows genome scale DNA sequence data to be presented within a clinically actionable diagnostic report. The company was founded by Matthew Hurles, Richard Durbin and Philip Beales in 2013 and is headquartered in Hinxton, the United Kingdom. | Biotechnology | Director/Board Member | |
ANATARA LIFESCIENCES LTD | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Cambridge Innovation Capital Ltd
Cambridge Innovation Capital Ltd Investment ManagersFinance Cambridge Innovation Capital Ltd (Cambridge Innovation Capital) is a venture capital firm founded in 2013. The firm is headquartered in Cambridge, United Kingdom. | Investment Managers | Chief Executive Officer | |
Wilson Parking New Zealand Ltd.
Wilson Parking New Zealand Ltd. Other Consumer ServicesConsumer Services Wilson Parking New Zealand Ltd. provides car parking management services. It also provides temporary parking usually on an hourly, daily, or monthly contract or fee basis in garages. The firm also operates car parks in office towers, airports, shopping centres, development sites, special event locations, hospitals, councils and across all of New Zealands main centres. It has offices in Auckland, Christchurch, Dunedin, Hamilton, Tauranga, Wellington, Queenstown and Invercargill. The company was founded in 1990 and is headquartered in Auckland, New Zealand. | Other Consumer Services | Director/Board Member | |
SpringWorks Therapeutics LLC
SpringWorks Therapeutics LLC BiotechnologyHealth Technology SpringWorks Therapeutics, Inc. engages in the development of biopharmaceutical products for patients with severe rare diseases and cancer. It focuses in advancing the pipeline of standalone and combination therapies with an initial focus on rare diseases and oncology. The company was founded by Lara S. Sullivan in 2017 and is headquartered in Stamford, CT. | Biotechnology | Director/Board Member | |
Valo Therapeutics Ltd. | Chief Executive Officer | ||
Transine Therapeutics Ltd.
Transine Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Transine Therapeutics Ltd. is an RNA platform company based in Cambridge, UK. The British company is developing a novel class of therapeutic RNAs called SINEUPs, which can upregulate protein expression with a superior level of control and specificity across an unprecedented range of diseases and applications. The company's proprietary technology allows them to address diseases that have been beyond the reach of small molecules, conventional biologics, or gene therapies. The SINEUP platform boosts the expression of almost any chosen target protein by binding precisely to the mRNA that encodes it and enhancing its translation. This technology massively extends the druggable proteome and represents an entirely new mechanism of action, ideally suited to address currently hard-to-treat diseases. The company was founded in 2018 by Stefano Gustincich and Piero Carninci. Jan Thirkettle has been the CEO of the company since 2021. | Pharmaceuticals: Major | Director/Board Member | |
Fesco Adecco
Fesco Adecco Personnel ServicesCommercial Services Fesco Adecco is a Chinese joint-venture human resources services company that provides corporate outsourcing, payroll service & dispatch, recruitment, employee welfare, and related HR solutions for more than 2,000,000 associates and more than 20,000 clients across China. The private company is based in Shanghai with regional branches in Beijing, Guangzhou, Shenzhen, and Shaanxi. Fesco Adecco combines the strengths of Fesco Group and Adecco Group, two leading companies in the human resources industry. The company aims to be the most admired workforce solutions partner through talent and technology. | Personnel Services | Director/Board Member | |
Horizon Discovery Ltd.
Horizon Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Horizon Discovery Ltd. develops and supplying patient-relevant drug discovery and diagnostic research tools. The frm also supplies genetically-defined cell lines, reporter gene assay kits, genomic reference standards and contract research services to organizations engaged in bio-pharmaceutical process optimization, drug discovery & development, and clinical diagnostic development. The company was founded by Christopher John Torrance and Alberto Bardelli on February 14, 2005 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member |
Statistics
International
United Kingdom | 32 |
Hong Kong | 5 |
Australia | 5 |
United States | 4 |
Germany | 3 |
Sectoral
Health Technology | 18 |
Commercial Services | 10 |
Consumer Services | 9 |
Communications | 5 |
Finance | 5 |
Operational
Director/Board Member | 87 |
Corporate Officer/Principal | 43 |
Chairman | 38 |
Independent Dir/Board Member | 22 |
Chief Executive Officer | 17 |
Most connected contacts
Insiders | |
---|---|
Iain Ross | 41 |
Charles Spicer | 27 |
Peter Stephen Keen | 25 |
Wolfgang Plischke | 21 |
David Prince | 13 |
Alan Keith Boyd | 12 |
Andrew Christie | 9 |
Paul Grant Higham | 8 |
David Venables | 8 |
David Philip Bloxham | 6 |
David Eckland | 6 |
Mark H. Richmond | 5 |
Nick Plummer | 4 |
Russell Banks | 3 |
Robert Shaw | 2 |
- Stock Market
- Insiders
- Martyn D. Williams
- Company connections